RAS-associated autoimmune leukoproliferative disorder (RALD) Caspase-8 deficiency (CEDS) Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation (IDAIL)
Supergrp
Disorders of adaptive immunity [DS:H02526] Primary immunodeficiency disease [DS:H01725]
Description
Autoimmune lymphoproliferative syndromes (ALPS) are autosomal dominant disorders with clinical features of various autoimmune manifestations that predominantly involve polyclonal accumulation of lymphocytes in the spleen and lymph nodes with lymphadenopathy and/or splenomegaly, and expansion of double-negative (DN) T cells in the peripheral blood. Central to the cellular pathogenesis is defective FAS-induced apoptosis, which in turn leads to dysregulation of lymphocyte homeostasis. ALPS caused by heterozygous mutations in the Fas gene (ALPS Type Ia) make up the majority of identified cases. However, other mutations, namely of the FasL gene (ALPS Type Ib) and the caspase 8 and 10 genes (ALPS Type II) are occasionally detected, whereas some patients do not present any known mutations (ALPS-III). Recently, mutations of the NRAS gene have been suggested to cause ALPS Type IV.
Category
Primary immunodeficiency
Brite
Human diseases in ICD-11 classification [BR:br08403]
04 Diseases of the immune system
Primary immunodeficiencies
4A01 Primary immunodeficiencies due to disorders of adaptive immunity
H00108 Autoimmune lymphoproliferative syndromes
Pathway-based classification of diseases [BR:br08402]
Cellular processes
nt06524 Apoptosis
H00108 Autoimmune lymphoproliferative syndromes
nt06527 Necroptosis
H00108 Autoimmune lymphoproliferative syndromes
Immune system
nt06537 TCR/BCR signaling
H00108 Autoimmune lymphoproliferative syndromes
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
